Pelican Therapeutics, Inc.

Selective Stimulation of Memory CD8+ T Cells

Selective Stimulation of Memory CD8+ T Cells

Introducing first-in-class therapeutics to achieve in vivo regulatory T cell expansion in humans

Introducing first-in-class therapeutics to achieve in vivo regulatory T cell expansion in humans

Oct 4, 2018

Heat Biologics’ Pelican Subsidiary Provides Update on its Novel PTX-35 T-Cell Costimulator

Oct 30, 2017

Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives Second Tranche of its $15.2 Million CPRIT Grant Award

Oct 23, 2017

Heat Biologics and its Pelican Therapeutics Subsidiary Appoint Two New Members to their Scientific Advisory Boards

Key Opinion Leaders Discuss PTX 35 for Oncology

Home About Us Products Science & Publications News Contact Us Careers

Copyright © 2022 Pelican Therapeutics, Inc., a subsidiary of Heat Biologics. All rights reserved. Privacy Policy Sitemap